May 23, 2012 — Boston Scientific Corp. announces that the Synergy everolimus-eluting bioabsorbable polymer-coated ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
May 23, 2012 — Boston Scientific Corp. announced two-year results from the PLATINUM Small Vessel study, demonstrating ...
May 22, 2012 — New long-term data from the DIVERGE study presented at EuroPCR 2012 showed that the use of the Axxess dru ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 15, 2012 –– As EuroPCR 2012 gets underway, Medtronic Inc.announced that the Resolute Integrity Coronary Stent System ...
May 15, 2012 — A simple clinical assessment performed in the doctor’s office can identify patients who are at high risk ...
May 14, 2012 -- Two types of stent systems are both effective in treating patients who have severe forms of peripheral ...
May 10, 2012 — New research confirms thrombus aspiration (TA) during percutaneous coronary intervention (PCI) in ...
May 4, 2012 - The U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the ...
April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides ...
April 12, 2012 – Abbott announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next ...
April 16, 2012 - 480 Biomedical announced that it has initiated the first human trial of its groundbreaking Stanza self ...
April 12, 2012 — The Maryland General Assembly set a high bar for the nation and showed its commitment to patients by ...
April 6, 2012 — Boston Scientific Corp. announced results from a quantitative coronary angiographic (QCA) analysis of ...
April 5, 2012 — Arterial Remodeling Technologies (ART) reported yesterday that in vivo data strongly suggest that its ...
April 2, 2012 — Boston Scientific announced its support of the HORIZONS II AMI clinical trial, which is designed to ...
May 23, 2012